F H Stewart
Affiliation: University of California
- Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidenceF H Stewart
Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 3333 California St, Suite 335, San Francisco, CA 94143 0744, USA
JAMA 285:2232-9. 2001....
- Abortion: teaching why as well as howFelicia H Stewart
Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA
Perspect Sex Reprod Health 35:37-9. 2003
- Knowledge of emergency contraception among women aged 18 to 44 in CaliforniaDiana G Foster
Center for Reproductive Health Research and Policy, University of California, San Francisco 94143 1744, USA
Am J Obstet Gynecol 191:150-6. 2004..By using data from the 1999-2001 California Women's Health Survey, we estimated the knowledge of emergency contraception among adult women of reproductive age at risk of pregnancy (n=6209)...
- A prescription for real securityFelicia H Stewart
Contraception 70:179-81. 2004
- Care for women choosing medication abortionDiana Taylor
Department of Family Health Care Nursing, University of California, San Francisco, USA
Nurse Pract 29:65-70. 2004
- Willing and able? Provision of medication for abortion by future internistsEleanor Bimla Schwarz
Department of Medicine, General Internal Medicine Section 111A1, University of California San Francisco, VA Medical Center, 4150 Clement Street, San Francisco, CA 94121, USA
Womens Health Issues 15:39-44. 2005..The development of medications such as mifepristone (RU486) has created the opportunity to introduce medication abortion as a component of office practice...
- A qualitative study of insurers' coverage for mifepristone-induced abortionMarcel P Gemperli
SCF, San Francisco, California 94143 1744, USA
Manag Care Interface 18:26-30, 32. 2005..A model coverage policy that contains comprehensive clinical information regarding appropriate clinical regimens for mifepristone is provided as an example for insurers and others in the field...
- Safety of mifepristone abortions in clinical useJillian T Henderson
Center for Reproductive Health Research and Policy, University of California, San Francisco, CA 94143, USA
Contraception 72:175-8. 2005..Extensive data from clinical trials document mifepristone's safety and efficacy for induced abortion, but less information is available about its safety in routine clinical use...
- Cervical cancer screening continues to limit provision of contraceptionEleanor Bimla Schwarz
General Internal Medicine Section, Department of Medicine, University of California, San Francisco UCSF, San Francisco, CA 94121, USA
Contraception 72:179-81. 2005..We assessed US obstetrician/gynecologists' practices regarding requirement of Pap testing before prescribing oral contraceptive or emergency contraceptive pills...
- Surrogate markers, emboldened and boxed warnings, and an expanding culture of misinformation: evidence-based clinical science should guide FDA decision making about product labelingLee P Shulman
Department of Obstetrics and Gynecology, Division of Reproductive Genetics, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
Contraception 73:440-2. 2006
- Expanded state-funded family planning services: estimating pregnancies averted by the Family PACT Program in California, 1997-1998Diana Greene Foster
University of California, San Francisco, 2356 Sutter St, Suite 200, UCSF Box 1744, San Francisco, CA 94143 1744, USA
Am J Public Health 94:1341-6. 2004..We estimated the impact on fertility of providing 500 000 women with contraceptives...
- Beyond access: acceptability, use and nonuse of emergency contraception among young womenCorinne H Rocca
Department of Obstetrics, Gynecology, and Reproductive Sciences, Bixby Center for Reproductive Health Research and Policy, School of Medicine, University of California, San Francisco, CA 94105, USA
Am J Obstet Gynecol 196:29.e1-6; discussion 90.e1-5. 2007..This study was undertaken to assess the acceptability of levonorgestrel emergency contraception (EC)...
- Title X: a sure-fire investment with at least a 300% returnFelicia H Stewart
Contraception 68:1. 2003
- Re: Advance supply of emergency contraceptionJames Trussell
J Pediatr Adolesc Gynecol 19:251. 2006
- ARHP editorialFelicia H Stewart
Contraception 67:341. 2003
- Keeping abortion legal: a look beyond Roe v. WadeFelicia H Stewart
Contraception 68:307-8. 2003
- Family planning in the balanceAnn C Hwang
Center for Reproductive Health Research and Policy, University of California, San Francisco, 94143, USA
Am J Public Health 94:15-8. 2004..In promoting an ideologically driven approach to sexual and reproductive health, the recent policy developments threaten to subvert ethical standards of medical care and the principle of evidence-based policy...
- A new year's resolution for reproductive health careFelicia H Stewart
Contraception 69:1-2. 2004
- Making research matterFelicia H Stewart
Contraception 69:87. 2004
- Ten priorities for women's healthAnn C Hwang
Contraception 70:265-8. 2004
- Presenting health risks honestly: mifepristone, a case in pointFelicia H Stewart
Contraception 69:177-8. 2004
- Family planning care: more than contraceptionFelicia H Stewart
Contraception 69:261-2. 2004
- The 2005 United States budget: wasteful expenditures, foregone opportunitiesFelicia H Stewart
Contraception 70:87-8. 2004
- The federal abortion ban: a clinical and moral dilemma, and international policy setbackFelicia H Stewart
Contraception 69:433-5. 2004
- Cairo goals for reproductive health: where do we stand at 10 years?Felicia H Stewart
Contraception 70:1-2. 2004